TGF-β signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro

Blood

Volumn 102, Issue 9, 2003, Pages 3129-3135

  Larsson, Jonas ^a   Blank, Ulrika ^b   Helgadottir, Hildur ^b   Björnsson, Jon Mar ^b   Ehinger, Mats ^b   Goumans, Marie José ^b   Fan, Xiaolong ^b   Levéen, Per ^b   Karlsson, Stefan ^b  

^a BMC   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CONTROLLED STUDY; DRUG POTENCY; GENE DISRUPTION; GENE INDUCTION; HEMATOPOIETIC STEM CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; REGULATORY MECHANISM; STEM CELL; TBRI GENE;

EID: 0142245613     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1300     Document Type: Article

References (39)

1. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor-β in human disease. N Engl J Med. 2000;342:1350-1358.
2. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis. Blood. 2000;96:2022-2036.
3. Sporn MB, Roberts AB. Peptide growth factors are multifunctional. Nature. 1988;332:217-219.
4. Massague J. TGF-β signal transduction. Annu Rev Biochem. 1998;67:753-791.
5. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature. 1994;371:257-261.
6. Geng Y, Weinberg RA. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci U S A. 1993;90:10315-10319.
7. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. TGF β inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell. 1993;74:1009-1020.
8. Keller JR, Mantel C, Sing GK, Ellingsworth LR, Ruscetti SK, Ruscetti FW. Transforming growth factor β1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J Exp Med. 1988;168:737-750.
9. Jacobsen SE, Keller JR, Ruscetti FW, Kondaiah P, Roberts AB, Falk LA. Bidirectional effects of transforming growth factor β (TGF-β) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-β isoforms. Blood. 1991;78:2239-2247.
10. Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH. Transforming growth factor β1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 1996;88:82-88.
11. Batard P, Monier MN, Fortunel N, et al. TGF-β1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci. 2000; 113:383-390.
12. Hatzfeld J, Li ML, Brown EL, et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. J Exp Med. 1991;174: 925-929.
13. Fortunel N, Batard P, Hatzfeld A, et al. High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells. J Cell Sci. 1998;111:1867-1875.
14. Soma T, Yu JM, Dunbar CE. Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-β but not macrophage inflammatory protein-1 α activities. Blood. 1996;87:4561-4567.
15. Le Bousse-Kerdiles MC, Chevillard S, Charpentier A, et al. Differential expression of transforming growth factor-β, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood. 1996;88:4534-4546.
16. DeCoteau JF, Knaus PI, Yankelev H, et al. Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1997;94:5877-5881.
17. Goey H, Keller JR, Back T, Longo DL, Ruscetti FW, Wiltrout RH. Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-β 1. J Immunol. 1989;143:877-880.
18. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693-699.
19. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993;90:770-774.
20. Christ M, McCartney-Francis NL, Kulkarni AB, et al. Immune dysregulation in TGF-β 1-deficient mice. J Immunol. 1994;153:1936-1946.
21. Diebold RJ, Eis MJ, Yin M, et al. Early-onset multifocal inflammation in the transforming growth factor β 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A. 1995;92:12215-12219.
22. Kulkarni AB, Ward JM, Yaswen L, et al. Transforming growth factor-β 1 null mice. An animal model for inflammatory disorders. Am J Pathol. 1995;146:264-275.
23. Oshima M, Oshima H, Taketo MM. TGF-β, receptor type II deficiency results in defects of yolk sac hematopoiesis and Vasculogenesis. Dev Biol. 1996;179:297-302.
24. Larsson J, Goumans MJ, Sjostrand LJ, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 2001;20:1663-1673.
25. Leveen P, Larsson J, Ehinger M, et al. Induced disruption of the transforming growth factor β type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood. 2002;100:560-568.
26. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 2002;21:1743-1753.
27. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269: 1427-1429.
28. Brakebusch C, Fillatreau S, Potocnik AJ, et al. β1 integrin is not essential for hematopoiesis but is necessary for the T cell-dependent IgM antibody response. Immunity. 2002;16:465-477.
29. Mikkola HK, Klintman J, Yang H, et al. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell cell leukaemia SCL/tal-1 gene. Nature. 2003;421: 547-551.
30. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hemaiopoietic stem cells. Blood. 1999;94:2548-2554.
31. Jacobsen FW, Stokke T, Jacobsen SE. Transforming growth factor-β potently inhibits the viability-promoting activity of stem cell factor and other cytokines and induces apoptosis of primitive murine hematopoietic progenitor cells. Blood. 1995;86:2957-2966.
32. Pantelouris EM. Absence of thymus in a mouse mutant. Nature. 1968;217:370-371.
33. Dybedal I, Jacobsen SE. Transforming growth factor β (TGF-β), a potent inhibitor of erythropoiesis: neutralizing TGF-β antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity. Blood. 1995;86:949-957.
34. Fan X, Valdimarsdottir G, Larsson J, et al. Transient disruption of autocrine TGF-β signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells. J Immunol. 2002;168:755-762.
35. Wang XJ, Greenhalgh DA, Bickenbach JR, et al. Expression of a dominant-negative type II transforming growth factor β (TGF-β) receptor in the epidermis of transgenic mice blocks TGF-β-mediated growth inhibition. Proc Natl Acad Sci U S A. 1997;94:2386-2391.
36. Dao MA, Taylor N, Nolta JA. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc Natl Acad Sci U S A. 1998;95:13006-13011.
37. Bhatia M, Bonnet D, Wu D, et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med. 1999;189:1139-1148.
38. Yu J. Involvement of activins and TGF-βs in hematopoiesis. In: Zon LI, ed. Hematopoiesis, a Developmental Approach. New York: Oxford University Press; 2001:299-307.
39. Pierelli L, Marone M, Bonanno G, et al. Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-β1 is a cell cycle-independent effect and influences their hematopoietic potential. Blood. 2000;95:3001-3009.